Predicting Peri-Operative Outcomes in Patients Treated with Percutaneous Thermal Ablation for Small Renal Masses: The SuNS Nephrometry Score

Author:

Musi Gennaro12,Luzzago Stefano12,Mauri Giovanni23ORCID,Mistretta Francesco Alessandro12,Varano Gianluca Maria3,Vaccaro Chiara1,Guzzo Sonia1,Maiettini Daniele3,Di Trapani Ettore1,Della Vigna Paolo3ORCID,Bianchi Roberto1ORCID,Bonomo Guido3,Ferro Matteo1ORCID,Tian Zhe4,Karakiewicz Pierre I.4,de Cobelli Ottavio12,Orsi Franco3ORCID,Piccinelli Mattia Luca14ORCID

Affiliation:

1. Department of Urology, IEO European Institute of Oncology, IRCCS, Via Ripamonti 435, 20141 Milan, Italy

2. Department of Oncology and Haemato-Oncology, Università degli Studi di Milano, 20122 Milan, Italy

3. Division of Interventional Radiology, IEO European Institute of Oncology, IRCCS, Via Ripamonti 435, 20141 Milan, Italy

4. Cancer Prognostics and Health Outcomes Unit, Division of Urology, University of Montréal Health Center, Montréal, QC H2X3E4, Canada

Abstract

Our objective was to develop a new, simple, and ablation-specific nephrometry score to predict peri-operative outcomes and to compare its predictive accuracy to PADUA and RENAL scores. Overall, 418 patients were treated with percutaneous thermal ablation (microwave and radiofrequency) between 2008 and 2021. The outcome of interest was trifecta status (achieved vs. not achieved): incomplete ablation or Clavien–Dindo ≥ 3 complications or postoperative estimated glomerular filtration rate decrease ≥ 30%. First, we validated the discrimination ability of the PADUA and RENAL scoring systems. Second, we created and internally validated a novel scoring (SuNS) system, according to multivariable logistic regression models. The predictive accuracy of the model was tested in terms of discrimination and calibration. Overall, 89 (21%) patients did not achieve trifecta. PADUA and RENAL scores showed poor ability to predict trifecta status (c-indexes 0.60 [0.53–0.67] and 0.62 [0.55–0.69], respectively). We, therefore, developed the SuNS model (c-index: 0.74 [0.67–0.79]) based on: (1) contact surface area; (2) nearness to renal sinus or urinary collecting system; (3) tumour diameter. Three complexity classes were created: low (3–4 points; 11% of no trifecta) vs. moderate (5–6 points; 30% of no trifecta) vs. high (7–8 points; 65% of no trifecta) complexity. Limitations include the retrospective and single-institution nature of the study. In conclusion, we developed an immediate, simple, and reproducible ablation-specific nephrometry score (SuNS) that outperformed PADUA and RENAL nephrometry scores in predicting peri-operative outcomes. External validation is required before daily practice implementation.

Publisher

MDPI AG

Subject

Clinical Biochemistry

Reference30 articles.

1. International Variations and Trends in Renal Cell Carcinoma Incidence and Mortality;Znaor;Eur. Urol.,2015

2. Effect of Stage and Grade Migration on Cancer Specific Mortality in Renal Cell Carcinoma Patients, According to Clear Cell vs. Non-Clear Cell Histology: A Contemporary Population-Based Analysis;Luzzago;Urol. Oncol. Semin. Orig. Investig.,2020

3. Ljungberg, B., Albiges, L., Bedke, J., Bex, A., Capitanio, U., Giles, R.H., Hora, M., Klatte, T., Marconi, L., and Powles, T. (2022, January 1–4). EAU Guidelines on Renal Cell Carcinoma—Edn. Presented at the 37th EAU Annual Congress Amsterdam, Amsterdam, The Netherlands.

4. Systematic Review and Meta-Analysis of Thermal Ablation versus Surgical Nephrectomy for Small Renal Tumours;Katsanos;Cardiovasc. Interv. Radiol.,2014

5. Tips and Tricks for a Safe and Effective Image-Guided Percutaneous Renal Tumour Ablation;Mauri;Insights Imaging,2017

Cited by 1 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3